Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.
Identifieur interne : 000604 ( PubMed/Checkpoint ); précédent : 000603; suivant : 000605Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.
Auteurs : E. Patois [Suisse] ; M A H. Capelle ; R. Gurny ; T. ArvinteSource :
- Vaccine [ 1873-2518 ] ; 2011.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
Abstract
The stability of different seasonal influenza vaccines was investigated by spectroscopy and microscopy methods before and after the following stress-conditions: (i) 2 and 4 weeks storage at 25°C, (ii) 1 day storage at 37°C and (iii) one freeze-thaw cycle. The subunit vaccine Influvac (Solvay Pharma) and the split vaccine Mutagrip (Sanofi Pasteur) were affected by all stresses. The split vaccine Fluarix (GlaxoSmithKline) was affected only by storage at 25°C. The virosomal vaccine Inflexal V (Berna Biotech) was stable after the temperature stresses but aggregated after one freeze-thaw cycle. This study provides new insights into commercial vaccines of low antigen concentration and highlights the importance of using multiple techniques to assess vaccine stability.
DOI: 10.1016/j.vaccine.2011.07.067
PubMed: 21803109
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:21803109Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.</title><author><name sortKey="Patois, E" sort="Patois, E" uniqKey="Patois E" first="E" last="Patois">E. Patois</name><affiliation wicri:level="4"><nlm:affiliation>School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest Ansermet 30, 1211 Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest Ansermet 30, 1211 Geneva</wicri:regionArea><orgName type="university">Université de Genève</orgName><placeName><settlement type="city">Genève</settlement><region nuts="3" type="region">Canton de Genève</region></placeName></affiliation></author><author><name sortKey="Capelle, M A H" sort="Capelle, M A H" uniqKey="Capelle M" first="M A H" last="Capelle">M A H. Capelle</name></author><author><name sortKey="Gurny, R" sort="Gurny, R" uniqKey="Gurny R" first="R" last="Gurny">R. Gurny</name></author><author><name sortKey="Arvinte, T" sort="Arvinte, T" uniqKey="Arvinte T" first="T" last="Arvinte">T. Arvinte</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21803109</idno><idno type="pmid">21803109</idno><idno type="doi">10.1016/j.vaccine.2011.07.067</idno><idno type="wicri:Area/PubMed/Corpus">000616</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000616</idno><idno type="wicri:Area/PubMed/Curation">000614</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000614</idno><idno type="wicri:Area/PubMed/Checkpoint">000604</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000604</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.</title><author><name sortKey="Patois, E" sort="Patois, E" uniqKey="Patois E" first="E" last="Patois">E. Patois</name><affiliation wicri:level="4"><nlm:affiliation>School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest Ansermet 30, 1211 Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest Ansermet 30, 1211 Geneva</wicri:regionArea><orgName type="university">Université de Genève</orgName><placeName><settlement type="city">Genève</settlement><region nuts="3" type="region">Canton de Genève</region></placeName></affiliation></author><author><name sortKey="Capelle, M A H" sort="Capelle, M A H" uniqKey="Capelle M" first="M A H" last="Capelle">M A H. Capelle</name></author><author><name sortKey="Gurny, R" sort="Gurny, R" uniqKey="Gurny R" first="R" last="Gurny">R. Gurny</name></author><author><name sortKey="Arvinte, T" sort="Arvinte, T" uniqKey="Arvinte T" first="T" last="Arvinte">T. Arvinte</name></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Drug Stability</term><term>Drug Storage</term><term>Influenza Vaccines</term><term>Microscopy, Fluorescence</term><term>Spectrometry, Fluorescence</term><term>Spectrum Analysis</term><term>Temperature</term><term>Vaccines, Subunit</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Analyse spectrale</term><term>Microscopie de fluorescence</term><term>Spectrométrie de fluorescence</term><term>Stabilité de médicament</term><term>Stockage de médicament</term><term>Température</term><term>Vaccins antigrippaux</term><term>Vaccins sous-unitaires</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Influenza Vaccines</term><term>Vaccines, Subunit</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Stability</term><term>Drug Storage</term><term>Microscopy, Fluorescence</term><term>Spectrometry, Fluorescence</term><term>Spectrum Analysis</term><term>Temperature</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Analyse spectrale</term><term>Microscopie de fluorescence</term><term>Spectrométrie de fluorescence</term><term>Stabilité de médicament</term><term>Stockage de médicament</term><term>Température</term><term>Vaccins antigrippaux</term><term>Vaccins sous-unitaires</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The stability of different seasonal influenza vaccines was investigated by spectroscopy and microscopy methods before and after the following stress-conditions: (i) 2 and 4 weeks storage at 25°C, (ii) 1 day storage at 37°C and (iii) one freeze-thaw cycle. The subunit vaccine Influvac (Solvay Pharma) and the split vaccine Mutagrip (Sanofi Pasteur) were affected by all stresses. The split vaccine Fluarix (GlaxoSmithKline) was affected only by storage at 25°C. The virosomal vaccine Inflexal V (Berna Biotech) was stable after the temperature stresses but aggregated after one freeze-thaw cycle. This study provides new insights into commercial vaccines of low antigen concentration and highlights the importance of using multiple techniques to assess vaccine stability.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21803109</PMID><DateCompleted><Year>2012</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2011</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>43</Issue><PubDate><Year>2011</Year><Month>Oct</Month><Day>06</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.</ArticleTitle><Pagination><MedlinePgn>7404-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2011.07.067</ELocationID><Abstract><AbstractText>The stability of different seasonal influenza vaccines was investigated by spectroscopy and microscopy methods before and after the following stress-conditions: (i) 2 and 4 weeks storage at 25°C, (ii) 1 day storage at 37°C and (iii) one freeze-thaw cycle. The subunit vaccine Influvac (Solvay Pharma) and the split vaccine Mutagrip (Sanofi Pasteur) were affected by all stresses. The split vaccine Fluarix (GlaxoSmithKline) was affected only by storage at 25°C. The virosomal vaccine Inflexal V (Berna Biotech) was stable after the temperature stresses but aggregated after one freeze-thaw cycle. This study provides new insights into commercial vaccines of low antigen concentration and highlights the importance of using multiple techniques to assess vaccine stability.</AbstractText><CopyrightInformation>Copyright © 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patois</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest Ansermet 30, 1211 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capelle</LastName><ForeName>M A H</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Gurny</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Arvinte</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022223">Vaccines, Subunit</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004355" MajorTopicYN="Y">Drug Stability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004356" MajorTopicYN="Y">Drug Storage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013050" MajorTopicYN="N">Spectrometry, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013057" MajorTopicYN="N">Spectrum Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022223" MajorTopicYN="N">Vaccines, Subunit</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>05</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>07</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>07</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21803109</ArticleId><ArticleId IdType="pii">S0264-410X(11)01112-1</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2011.07.067</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Suisse</li></country><region><li>Canton de Genève</li></region><settlement><li>Genève</li></settlement><orgName><li>Université de Genève</li></orgName></list><tree><noCountry><name sortKey="Arvinte, T" sort="Arvinte, T" uniqKey="Arvinte T" first="T" last="Arvinte">T. Arvinte</name><name sortKey="Capelle, M A H" sort="Capelle, M A H" uniqKey="Capelle M" first="M A H" last="Capelle">M A H. Capelle</name><name sortKey="Gurny, R" sort="Gurny, R" uniqKey="Gurny R" first="R" last="Gurny">R. Gurny</name></noCountry><country name="Suisse"><region name="Canton de Genève"><name sortKey="Patois, E" sort="Patois, E" uniqKey="Patois E" first="E" last="Patois">E. Patois</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000604 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000604 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:21803109
|texte= Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:21803109" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a StressCovidV1
| This area was generated with Dilib version V0.6.33. |  |